← Back to Search

Electromagnetic Therapy

PEMF Therapy for Osteoarthritis

N/A
Recruiting
Led By Raymond Chou, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Reported pain intensity during activities of daily living less than 7 on the Numeric Pain Rating Scale (NPRS)
reported pain intensity during activities of daily living less than 8 on the Numeric Pain Rating Scale (NPRS)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 and 6 weeks
Awards & highlights

Study Summary

This trial will study if a high-frequency PEMF therapy device can help reduce pain and improve function for people with thumb CMC joint osteoarthritis. The study will last for 8 weeks and will compare those who use the therapy device to those who use a sham device.

Who is the study for?
This trial is for people with thumb CMC joint osteoarthritis confirmed by a hand specialist, who feel pain less than 7 or 8 on the NPRS during daily activities. It's not for those who've had surgery for CMC OA, don't speak English, have heart/brain implants, are pregnant, or have other significant hand issues.Check my eligibility
What is being tested?
The study tests if high-frequency PEMF therapy can reduce pain in patients with thumb arthritis. Sixty participants will be split into two groups: one receiving real PEMF treatment and the other a sham device over four weeks, with follow-up at six weeks.See study design
What are the potential side effects?
PEMF therapy is generally considered safe but may cause discomfort or skin irritation where applied. The sham device should not cause any side effects as it's inactive; however, individual reactions to wearing the device overnight may vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My pain level during daily activities is below 7.
Select...
My pain level during daily activities is below 8 on a scale of 0-10.
Select...
I have thumb joint pain confirmed by a doctor's exam or X-rays.
Select...
I have been diagnosed with thumb arthritis by a hand specialist.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 and 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Numeric Pain Rating Scale (NPRS)
Hand
Single Assessment Numeric Evaluation (SANE)

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PEMF deviceExperimental Treatment1 Intervention
Group II: Sham PEMF devicePlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,378 Previous Clinical Trials
17,333,299 Total Patients Enrolled
16 Trials studying Osteoarthritis
4,995 Patients Enrolled for Osteoarthritis
Raymond Chou, MDPrincipal InvestigatorStanford University

Media Library

PEMF device (Electromagnetic Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05315297 — N/A
Osteoarthritis Research Study Groups: PEMF device, Sham PEMF device
Osteoarthritis Clinical Trial 2023: PEMF device Highlights & Side Effects. Trial Name: NCT05315297 — N/A
PEMF device (Electromagnetic Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05315297 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study actively seeking participants at this time?

"As per clinicaltrials.gov's records, this particular trial is not presently enrolling patients; the project was uploaded on December 1st 2022 and updated on September 29th 2022. Despite this research study being inactive at present, there are 923 other medical trials actively seeking participants."

Answered by AI

Who else is applying?

What state do they live in?
South Dakota
How old are they?
65+
What portion of applicants met pre-screening criteria?
Met criteria

How responsive is this trial?

Typically responds via
Email
~21 spots leftby Aug 2024